GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Capex-to-Operating-Income

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Capex-to-Operating-Income : 0.00 (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Cannabis Bioscience International Holdings's Capital Expenditure for the six months ended in Nov. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Nov. 2023 was $-0.27 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Cannabis Bioscience International Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Capex-to-Operating-Income Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Capex-to-Operating-Income
- - 0.17 - 0.07

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.14 0.58 - -

Competitive Comparison of Cannabis Bioscience International Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Capex-to-Operating-Income falls into.



Cannabis Bioscience International Holdings Capex-to-Operating-Income Calculation

Cannabis Bioscience International Holdings's Capex-to-Operating-Income for the fiscal year that ended in May. 2011 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.924) / 14.308
=0.06

Cannabis Bioscience International Holdings's Capex-to-Operating-Income for the quarter that ended in Nov. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.268
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Cannabis Bioscience International Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines